By Kate Thompson
Could there be one factor that links together conflict, climate change, racism, anxiety and eating disorders?
Read on volteface.me
CLEAR ALL
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
2
A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).
Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters.
1
In an appropriate context, ayahuasca can be a valuable therapeutic tool and can act as a catalyst that can render psychotherapeutic processes more effective in less time, and sometimes allow for critical interventions when several other therapeutic strategies have been unsuccessful.
Badass women making waves in the psychedelic movement, from research to drug policy reform.
The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.
Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
Amazonian healing traditions collide with Western medical sensibilities.
A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.